2070
I. Yavari et al. / Tetrahedron 65 (2009) 2067–2071
3.2.4. Di(tert-butyl) 1-benzoylpyrrolo[2,1-a]isoquinoline-2,3-
dicarboxylate (4d)
136.1 (CH), 142.4 (C), 152.1 (C), 159.8 (C), 164.9 (C), 180.8 (C]O),
184.2 (C]O), 186.5 (C]O) ppm.
Yellow crystals, mp 164–166 ꢁC, 0.71 g, yield 76%. IR (KBr) (nmax
/
cmꢀ1): 1723 (C]O), 1717 (C]O), 1681 (C]O), 1659, 1368, 1201. MS,
m/z (%): 471 (Mþ, 9), 394 (100), 368 (14), 105 (31), 77 (59). Anal.
Calcd for C29H29NO5 (471.55): C, 73.87; H, 6.20; N, 2.97%. Found: C,
3.3. General procedure for the synthesis of compounds
11 and 12
74.08; H, 6.03; N, 3.16%. 1H NMR:
d
1.28 (9H, s, CMe3), 1.58 (9H, s,
To a stirred solution of 2a (0.28 g, 2 mmol) and 3a (2 mmol) in
5 mL of H2O/MeCN (5:1) was added quinoline or benzothiazole
(2 mmol) at rt. The reaction mixture was then stirred for 5 h. The
precipitates were filtered and recrystallized from methanol to give
the title compounds.
CMe3), 7.00 (1H, d, 3J¼7.6 Hz, CH), 7.25 (1H, t, 3J¼7.7 Hz, CH), 7.37
(1H, t, 3J¼7.9 Hz, CH), 7.39 (2H, t, 3J¼7.6 Hz, 2CH), 7.52 (1H, t,
3J¼7.7 Hz, CH), 7.57 (1H, d, 3J¼7.7 Hz, CH), 7.82 (1H, d, 3J¼8.3 Hz,
CH), 7.96 (2H, d, 3J¼7.5 Hz, 2CH), 9.10 (1H, d, 3J¼7.6 Hz, CH) ppm.
13C NMR:
d 27.3 (CMe3), 28.1 (CMe3), 82.0 (CMe3), 82.6 (CMe3), 114.6
(CH), 116.4 (C), 116.5 (C), 123.8 (CH), 124.2 (C), 124.4 (CH), 126.1 (C),
127.0 (CH), 127.8 (CH), 127.9 (CH), 128.6 (C), 128.7 (2CH), 129.9
(2CH), 130.2 (C), 133.6 (CH), 138.0 (C), 160.1 (C]O), 162.4 (C]O),
193.9 (C]O) ppm.
3.3.1. Dimethyl 3-benzoylpyrrolo[1,2-a]quinoline-1,2-
dicarboxylate (11)
Pale yellow powder, mp 100–102 ꢁC, 0.49 g, yield 63%. IR (KBr)
(
nmax/cmꢀ1): 1734 (C]O), 1730 (C]O), 1681 (C]O), 1643, 1356,
1205. MS, m/z (%): 387 (Mþ, 8), 310 (100), 284 (11), 105 (36), 77
3.2.5. Dimethyl 1-(4-methyl)benzoylpyrrolo[2,1-a]isoquinoline-
2,3-dicarboxylate (4e)
(68). Anal. Calcd for C23H17NO5 (387.38): C, 71.31; H, 4.42; N,
3.62%. Found: C, 71.39; H, 4.57; N, 3.77%. 1H NMR:
d 3.72 (3H, s,
Pale yellow crystals, mp 207–209 ꢁC, 0.60 g, yield 75%. IR (KBr)
OMe), 4.03 (3H, s, OMe), 7.43 (1H, d, 3J¼7.5 Hz, CH), 7.45 (2H, t,
3J¼7.5 Hz, 2CH), 7.48 (1H, t, 3J¼7.5 Hz, 2CH), 7.50 (1H, t, 3J¼7.6 Hz,
CH), 7.77 (1H, t, 3J¼8.1 Hz, CH), 7.80 (1H, d, 3J¼8.2 Hz, 1CH), 7.87
(1H, d, 3J¼8.1 Hz, 2CH), 8.10 (2H, d, 3J¼7.7 Hz, 2CH), 8.21 (1H, d,
(
nmax/cmꢀ1): 1732 (C]O), 1729 (C]O), 1692 (C]O), 1637, 1361,
1213. MS, m/z (%): 401 (Mþ, 6), 324 (100), 298 (10), 105 (20), 77
(70). Anal. Calcd for C24H19NO5 (401.41): C, 71.81; H, 4.77; N,
3.49%. Found: C, 71.78; H, 4.54; N, 3.78%. 1H NMR:
d
2.43 (3H, s,
3J¼7.5 Hz, CH) ppm. 13C NMR:
d 51.8 (OMe), 53.2 (OMe), 117.5 (C),
Me), 3.56 (3H, s, OMe), 3.94 (3H, s, OMe), 7.18 (1H, d, 3J¼7.5 Hz,
CH), 7.25 (2H, d, 3J¼7.6 Hz, 2CH), 7.37 (1H, t, 3J¼7.5 Hz, 1CH), 7.50
(1H, t, 3J¼7.3 Hz, CH), 7.68 (1H, d, 3J¼7.7 Hz, CH), 7.83 (2H, d,
3J¼7.6 Hz, 2CH), 8.05 (1H, d, 3J¼7.4 Hz, 1CH), 9.21 (1H, d,
117.7 (CH), 121.1 (CH), 125.4 (C), 125.8 (CH), 125.9 (C), 126.7 (CH),
128.3 (C), 128.4 (2CH), 128.8 (C), 128.9 (2CH), 129.1 (CH), 129.2 (C),
129.6 (CH), 129.9 (CH), 130.5 (C), 159.9 (C]O), 163.4 (C]O), 191.3
(C]O) ppm.
3J¼7.5 Hz, CH) ppm. 13C NMR:
d 22.2 (Me), 52.5 (OMe), 52.7
(OMe), 114.7 (C), 116.0 (CH), 117.8 (C), 124.4 (CH), 124.8 (C), 125.7
(CH), 127.3 (C), 127.7 (CH), 128.6 (CH), 129.1 (CH), 129.6 (C), 129.7
(2CH), 130.4 (2CH), 132.3 (C), 136.4 (C), 144.9 (C), 161.4 (C]O),
165.4 (C]O), 193.6 (C]O) ppm.
3.3.2. Dimethyl 3-benzoylpyrrolo[2,1-b][1,3]benzothiazole-1,2-
dicarboxylate (12)
Pale yellow powder, mp 100–102 ꢁC, 0.44 g, yield 56%. IR (KBr)
(
nmax/cmꢀ1): 1722 (C]O), 1719 (C]O), 1679 (C]O), 1654, 1355,
1200. MS, m/z (%): 393 (Mþ, 9), 316 (100), 290 (20),105 (28), 77 (57).
3.2.6. Diethyl 1-(4-methyl)benzoylpyrrolo[2,1-a]isoquinoline-2,3-
dicarboxylate (4f)
Anal. Calcd for C21H15NO5S (393.41): C, 64.11; H, 3.84; N, 3.56%.
Found: C, 64.36; H, 3.65; N, 3.68%. 1H NMR:
d 3.53 (3H, s, OMe), 3.93
Pale yellow crystals, mp 165–167 ꢁC, 0.61 g, yield 71%. IR (KBr)
(3H, s, OMe), 7.45 (2H, t, 3J¼7.7 Hz, CH), 7.49 (1H, t, 3J¼7.7 Hz, CH),
7.52 (1H, t, 3J¼7.7 Hz, CH), 7.69 (2H, d, 3J¼8.4 Hz, 2CH), 7.72 (1H, t,
3J¼7.7 Hz, CH), 7.87 (1H, d, 3J¼7.7 Hz, CH), 8.95 (1H, d, 3J¼8.3 Hz,
(
nmax/cmꢀ1): 1733 (C]O), 1732 (C]O), 1683 (C]O), 1638, 1362,
1211. MS, m/z (%): 429 (Mþ, 8), 352 (100), 326 (14), 105 (25), 77 (65).
Anal. Calcd for C26H23NO5 (429.44): C, 72.72; H, 5.36; N, 3.26%.
CH) ppm. 13C NMR:
d 51.8 (OMe), 51.9 (OMe), 117.6 (C), 123.0 (C),
Found: C, 72.68; H, 5.27; N, 3.48%. 1H NMR:
d
1.12 (3H, t, 3J¼7.3 Hz,
125.2 (CH), 126.3 (C), 127.9 (2CH), 128.7 (2CH), 129.0 (C), 129.9 (CH),
131.2 (CH),132.9 (C),133.1 (C),134.4 (CH),138.3 (CH),142.5(C),159.6
(C]O), 164.2 (C]O), 188.8 (C]O) ppm.
Me), 1.45 (3H, t, 3J¼7.3 Hz, Me), 2.40 (3H, s, Me), 3.90 (2H, q,
3J¼7.3 Hz, OCH2), 4.06 (2H, q, 3J¼7.3 Hz, OCH2), 7.19 (1H, d,
3J¼7.5 Hz, CH), 7.27 (2H, d, 3J¼7.6 Hz, 2CH), 7.35 (1H, t, 3J¼7.5 Hz,
1CH), 7.48 (1H, t, 3J¼7.3 Hz, CH), 7.61 (1H, d, 3J¼7.7 Hz, CH), 7.80
(2H, d, 3J¼7.6 Hz, 2CH), 8.10 (1H, d, 3J¼7.4 Hz, 1CH), 9.23 (1H, d,
3.4. General procedure for the synthesis of functionalized
isoxazoles 14
3J¼7.5 Hz, CH) ppm. 13C NMR:
d 13.9 (Me), 14.4 (Me), 22.4 (Me), 61.1
(OCH2), 62.3 (OCH2),114.8 (C),116.1 (CH),118.7 (C), 124.6 (CH),125.0
(C), 125.4 (CH), 126.9 (C), 127.6 (CH), 128.4 (CH), 128.9 (CH), 129.3
(C), 129.9 (2CH), 131.3 (2CH), 131.9 (C), 135.4 (C), 144.7 (C), 160.8
(C]O), 164.9 (C]O), 192.8 (C]O) ppm.
To a stirred solution of 2 (2 mmol) and 13 (2 mmol) in 5 mL of
H2O/MeCN (5:1) was added pyridine or N-methylimidazole
(20 mol %) at rt. The reaction mixture was then stirred for 6 h. The
solvent was removed under reduced pressure and the viscous
residue was purified by column chromatography (Merck 230–400
mesh) using n-hexane/EtOAc (4:1) as eluent. Compounds 14a–e are
reported previously.16
3.2.7. 1,2,3-Tribenzoylpyrrolo[2,1-a]isoquinoline (4g)
Pale yellow crystals, mp 135–137 ꢁC, 0.81 g, yield 85%. IR (KBr)
(
nmax/cmꢀ1): 1674 (C]O), 1640 (C]O), 1593 (C]O), 1232, 958, 557.
MS, m/z (%): 479 (Mþ, 10), 402 (100), 376 (16), 105 (33), 77 (63).
3.4.1. Dimethyl 3-benzoyl-isoxazole-4,5-dicarboxylate (14f)
Anal. Calcd for C33H21NO3 (479.53): C, 82.66; H, 4.41; N, 2.92%.
Pale yellow powder, mp 91–93 ꢁC [lit.22 88–89 ꢁC] 0.41 g, yield
70%. IR (KBr) (nmax/cmꢀ1): 1746 (C]O), 1743 (C]O), 1738 (C]O),
1646, 1580, 1282. MS, m/z (%): 289 (Mþ, 10), 212 (100), 186 (22), 105
(57), 77 (75). Anal. Calcd for C14H11NO6 (289.24): C, 58.14; H, 3.83;
Found: C, 82.88; H, 4.54; N, 3.06%. 1H NMR:
d
7.54 (2H, t, 3J¼7.7 Hz,
2CH), 7.57–7.63 (4H, m, 4CH), 7.68 (1H, t, 3J¼7.4 Hz, CH), 7.74–7.80
(3H, m, 3CH), 7.84 (1H, d, 3J¼7.2 Hz, CH), 7.88 (2H, d, 3J¼8.3 Hz, CH),
7.97 (1H, d, 3J¼8.2 Hz, CH), 8.06 (2H, d, 3J¼8.3 Hz, 2CH), 8.15 (1H, d,
3J¼8.1 Hz, CH), 8.17 (2H, d, 3J¼7.3 Hz, 2CH), 8.52 (1H, d, 3J¼7.5 Hz,
N, 4.84%. Found: C, 59.78; H, 5.60; N, 6.98%. 1H NMR:
d 3.87 (3H, s,
OMe), 4.00 (3H, s, OMe), 7.50 (2H, t, 3J¼6.6 Hz, 2CH), 7.65 (1H, t,
CH), 9.33 (1H, d, 3J¼7.4 Hz, CH) ppm. 13C NMR:
d
115.4 (C), 123.8 (C),
3J¼6.8 Hz, CH), 8.13 (2H, d, 3J¼7.17 Hz, 2CH) ppm. 13C NMR:
d 53.2
126.3 (CH), 127.1 (C), 125.5 (C), 128.7 (2CH), 128.9 (2CH), 129.0
(2CH), 129.2 (2CH), 129.8 (2CH), 130.0 (C), 130.3 (2CH), 130.7 (CH),
134.2 (CH),134.4 (CH),134.5 (CH), 134.9 (CH),135.1 (CH),135.2 (CH),
(OMe), 53.6 (OMe), 117.6 (C), 128.8 (2CH), 130.5 (2CH), 134.8 (CH),
134.9 (C), 155.9 (C), 159.1 (C), 159.9 (C]O), 160.1 (C]O), 183.7
(C]O) ppm.